
Please try another search
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company’s medical-related business includes its dispensing pharmacy and other medical-related businesses. The company was incorporated in 2003 and is based in Tokyo, Japan.
Name | Age | Since | Title |
---|---|---|---|
Toshie Takeuchi | 70 | 2020 | Independent Outside Director |
Takashi Ito | 65 | 2018 | Independent Outside Director |
Manabu Kinoshita | 71 | 2020 | Independent Outside Director |
Kimiko Kunimasa | 65 | 2022 | Independent Outside Director |
Sachiko Iizuka | 56 | 2025 | Independent Outside Director |
Yuji Ueda | 64 | 2022 | Director |
Hiroshi Kizaki | 66 | 2023 | Independent Outside Director |
Ryuji Arakawa | 62 | 2016 | President & Representative Director |
Yusuke Fukujin | 49 | 2020 | Executive VP & Representative Director |
Toshiki Tanaka | 62 | 2022 | Managing Executive Officer of Corporate Affairs & Director |
Shigeki Ohashi | 60 | 2022 | Managing Executive Officer of Business Strategy & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review